ArticleBritish journal of clinical pharmacology2005

Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions.

Daniele Fabio Zullino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.